C12Y 304/21062
Subtilisin
Official title: Subtilisin (3.4.21.62)
C12Y304/21062 (Subtilisin) appears on 226 US grants and 508 published applications in this corpus.
Search patents in C12Y- Granted patents
- 226
- Published applications
- 508
- Assignees
- 143
- Inventors
- 815
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 1 | 6 |
| 2003 | 1 | 10 |
| 2004 | 6 | 6 |
| 2005 | 2 | 5 |
| 2006 | 1 | 2 |
| 2007 | 3 | 2 |
| 2008 | 1 | 11 |
| 2009 | 0 | 6 |
| 2010 | 2 | 7 |
| 2011 | 2 | 17 |
| 2012 | 1 | 10 |
| 2013 | 5 | 13 |
| 2014 | 7 | 16 |
| 2015 | 8 | 33 |
| 2016 | 5 | 27 |
| 2017 | 5 | 33 |
| 2018 | 12 | 41 |
| 2019 | 18 | 34 |
| 2020 | 26 | 39 |
| 2021 | 25 | 24 |
| 2022 | 16 | 35 |
| 2023 | 16 | 36 |
| 2024 | 13 | 35 |
| 2025 | 25 | 27 |
| 2026 | 17 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cleaning compositions comprising dispersins VI29 Sep 2026US 12,747,416 B2Henkel AG & Co. KGaA
- Subtilisin variants and methods of use1 Sep 2026US 12,723,239 B2Danisco US Inc.
- Subtilase variants and polynucleotides encoding same11 Aug 2026US 12,703,862 B2Novozymes A/S
- Animal feed additives comprising a polypeptide having protease activity and uses thereof16 Jun 2026US 12,653,209 B2Novozymes A/S
- Compositions for producing fermentation products16 Jun 2026US 12,655,402 B2Novozymes A/S
- Subtilisin variants and methods of use3 Sep 2026US 2026/0258389 A1Danisco US Inc.
- Variant subtilisin proteases3 Sep 2026US 2026/0258390 A1Peaccel
- Producing Engineered Cells by Introducing Cas9/sgRNA Complexes27 Aug 2026US 2026/0250690 A1Toolgen Incorporated
- Inoculum composition for accelerating anaerobic biodegradation of plastics and methods for producing the same20 Aug 2026US 2026/0242562 A1Nano and Advanced Materials Institute Limited
- Vitro and Ex Vivo Methods for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells13 Aug 2026US 2026/0234641 A1Toolgen Incorporated
Most cited
By later US patents
- Multiply-substituted protease variants83US 6,312,936 B1Genencor International, Inc. · 2001
- Multiply-substituted protease variants47US 6,482,628 B1Genencor International, Inc. · 2002
- Methods for cleaving a target DNA using a guide RNA specific for the target DNA and Cas protein-encoding nucleic acid or Cas protein42US 10,851,380 B2Toolgen Incorporated · 2020
- Controlled dissolution crosslinked protein crystals40US 6,140,475 AAltus Biologics Inc. · 2000
- Protein hydrolysate derived from mucosa tissue24US 5,607,840 ACelsus, Inc. · 1997